STOCK-BASED COMPENSATION | 13 – STOCK-BASED COMPENSATION 2015 Equity Incentive Plan Stock Options The following table summarizes the stock option activity for the six months ended June 30, 2023: Weighted Weighted Number Average Average of Exercise Fair Options Price Value Outstanding as of January 1, 2023 415,227 $ 7.91 $ 2.78 Granted — — — Exercised (47,037) 7.70 2.53 Forfeited — — — Outstanding as of June 30, 2023 368,190 $ 7.93 $ 2.82 Exercisable as of June 30, 2023 331,880 $ 7.72 $ 2.65 The following table summarizes certain information about the options outstanding as of June 30, 2023: Options Outstanding and Unvested, Options Outstanding and Exercisable, June 30, 2023 June 30, 2023 Weighted Weighted Weighted Average Weighted Average Weighted Average Exercise Price of Average Remaining Average Remaining Outstanding Number of Exercise Contractual Number of Exercise Contractual Options Options Price Life Options Price Life $ 7.93 36,310 $ 9.91 3.65 331,880 $ 7.72 2.74 As of June 30, 2023 and December 31, 2022, a total of 368,190 and 415,227 stock options were outstanding, respectively. The unamortized stock-based compensation balance of $32 as of June 30, 2023 is expected to be expensed $25 and $7 during the remainder of 2023 and during the year ending December 31, 2024, respectively. F or the three and six months ended June 30, 2023 and 2022, the Company recognized amortization expense of the fair value of its stock options, which is included in General and administrative expenses, as follows: For the Three Months Ended For the Six Months Ended June 30, June 30, 2023 2022 2023 2022 General and administrative expenses $ 15 $ 55 $ 58 $ 168 Restricted Stock Units The Company has granted restricted stock units (“RSUs”) under the 2015 Plan to certain members of the Board of Directors and certain executives and employees of the Company, which represent the right to receive a share of common stock, or in the sole discretion of the Company’s Compensation Committee, the value of a share of common stock on the date that the RSU vests. As of June 30, 2023 and December 31, 2022, 790,610 and 612,300 shares of the Company’s common stock were outstanding in respect of the RSUs, respectively. Such shares will only be issued in respect to vested RSUs issued to directors when the director’s service with the Company as a director terminates. Such shares of common stock will only be issued to executives and employees when their RSUs vest under the terms of their grant agreements and the amended 2015 Plan. The RSUs that have been issued to certain members of the Board of Directors generally vest on the date of the annual shareholders meeting of the Company following the date of the grant. three anniversaries of the determined vesting date. The table below summarizes the Company’s unvested RSUs for the six months ended June 30, 2023: Weighted Number of Average Grant RSUs Date Price Outstanding as of January 1, 2023 641,972 $ 15.74 Granted 205,118 16.30 Vested (219,649) 14.32 Forfeited (49,322) 16.42 Outstanding as of June 30, 2023 578,119 $ 16.41 The total fair value of the RSUs that vested during the six months ended June 30, 2023 and 2022 was $3,923 and $3,733 , respectively. The total fair value is calculated as the number of shares vested during the period multiplied by the fair value on the vesting date. The following table summarizes certain information of the RSUs unvested and vested as of June 30, 2023: Unvested RSUs Vested RSUs June 30, 2023 June 30, 2023 Weighted Weighted Average Weighted Average Remaining Average Number of Grant Date Contractual Number of Grant Date RSUs Price Life RSUs Price 578,119 $ 16.41 1.84 285,259 $ 12.33 The Company is amortizing these grants over the applicable vesting periods, net of anticipated forfeitures. As of June 30, 2023, unrecognized compensation cost of For the three and six months ended June 30, 2023 and 2022, the Company recognized nonvested stock amortization expense for the RSUs, which is included in General and administrative expenses as follows: For the Three Months Ended For the Six Months Ended June 30, June 30, 2023 2022 2023 2022 General and administrative expenses $ 1,089 $ 771 $ 2,605 $ 1,348 Performance-Based Restricted Stock Units The Company has granted performance-based restricted stock units (“PRSUs”) under the 2015 Plan to certain employees of the Company, some of which are contingent upon the Company’s relative total shareholder return (“TSR”) and some of which are contingent upon the Company’s return on invested capital (”ROIC”) for a three-year performance period ending December 31, 2025. The TSR is calculated based on the Company’s total shareholder return compared to that of certain peer companies specified in the award agreements over the performance period and is calculated based on the change in the average daily closing stock price over a 20 trading-day period from the beginning to the end of the performance period, including reinvested dividends. The total quantity of PRSUs eligible to vest under these awards range from zero to 200% of the target based on actual relative TSR performance during the performance period. The grant date fair value of the TSR awards was estimated using a Monte Carlo simulation model. Compensation for these awards, which are subject to market conditions, is being amortized over the service period. The grant date fair value of the ROIC awards was estimated using the closing share price of the Company’s stock on the date of grant. The total quantity of PRSUs eligible to vest under these awards range from zero to 200% of the target based on actual ROIC performance during the performance period. As such ROIC awards are subject to performance conditions and compensation cost is recognized over the service period based on the amount of awards that the Company believes is probable that will vest. To the extent the Company’s estimate changes, the Company will recognize a cumulative catch up in subsequent reporting periods. The PRSUs, if earned, will ordinarily vest during the first quarter of 2026 and the recipient will receive a share of common stock for each earned PRSU. If PRSUs. However, based on actual performance, the number of PRSUs earned will change based on the ranges described above. As of June 30, 2023, unrecognized compensation cost of Significant inputs used in the estimation of the fair value of these awards granted during the three and six months ended June 30, 2023 are as follows: Significant Input June 30, 2023 Closing share price of our common stock $14.36 to $16.30 Risk-free rate of return 3.81% to 4.38% Expected volatility of our common stock 53.38% to 54.53% Holding period discount 0% Simulation term (in years) 2.54 to 2.72 Range of target 0% to 200% For the three and six months ended June 30, 2023 and 2022, the Company recognized nonvested stock amortization expense for the PRSUs, which is included in General and administrative expenses as follows: For the Three Months Ended For the Six Months Ended June 30, June 30, 2023 2022 2023 2022 General and administrative expenses $ 115 $ — $ 115 $ — |